EMAIL US: customerservice@franklinyoung.com
CALL US: (618) 724-2780 / (909) 931-5012
CALL US: (618) 724-2780 / (909) 931-5012
Back to Previous Page
ITEM#: 2013-NEX207010UC
MFR#: NEX207010UC
This is a radioactive product - shipping address must have a license to receive radioactive materials. Glucagon, Receptor Grade, [125I]-, 10µCi.Glucagon, labeled with 125I. This product is receptor grade, and was developed for use in receptor bindin
| Product Name | Description | Item# | QTY | |
|---|---|---|---|---|
Glucagon, Receptor Grade, [125I]-, 50µCi
|
This is a radioactive product - shipping address must have a license to receive radioactive materials. Glucagon, Receptor Grade, [125I]-, 50µCi.Glucagon, labeled with 125I. This product is receptor grade, and was developed for use in receptor bindin | 2013-NEX207050UC | EA | |
Insulin (porcine), Receptor Grade, [125I]TyrA14, 10µCi
|
This is a radioactive product - shipping address must have a license to receive radioactive materials. Insulin (porcine), Receptor Grade, [125I]TyrA14, 10µCi.Porcine insulin, labeled with 125I on tyrosineA14. This product is receptor-grade, and was | 2013-NEX196010UC | EA | |
Epibatidine, ([125I]-IPH), [125I]-, 10µCi
|
This is a radioactive product - shipping address must have a license to receive radioactive materials. Epibatidine, ([125I]-IPH), [125I]-, 10µCi.Epibatidine, labeled with 125I. Epibatidine has analgesic activities, has been shown to function as an a | 2013-NEX358010UC | EA | |
Somatostatin, [125I]Tyr11, 10µCi
|
This is a radioactive product - shipping address must have a license to receive radioactive materials. Somatostatin, [125I]Tyr11, 10µCi.Somatostatin, labeled with 125I. Somatostatin binds somatostatin receptors, and inhibits the secretion of insulin | 2013-NEX389010UC | EA | |
Orexin A, [125I]-, 10µCi (370kBq)
|
This is a radioactive product - shipping address must have a license to receive radioactive materials. Orexin A, [125I]-, 10µCi (370kBq).Orexin A, labeled with 125I. Orexin A binds to orexin receptors (OX1 and OX2), which are potential drug targets | 2013-NEX367010UC | EA |